Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...
The FDA granted priority review, with a decision expected by June 19, 2025. LEN represents a novel class of HIV therapies by targeting the viral capsid, a multifunctional protein essential for HIV ...
A Bioengineering degree in one university may look very similar to a Biological Engineering degree somewhere else. Always go through the syllabus, lab facilities, internships, and faculty research ...
We will conduct innovative research that provides new fundamental knowledge and addresses societal challenges. We conduct impactful chemical and biological engineering research that addresses societal ...
High-quality HIV antigens for cutting-edge solutions. On February 18, 2025, Gilead Sciences (CA, US) announced a significant milestone: the US FDA accepted their New Drug Applications (NDAs) for ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results